ArticleJACC. Basic to translational science2021

Leveraging FPR2 Agonists to Resolve Inflammation and Improve Outcomes Following Myocardial Infarction.

Andrew L Koenig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.